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Abstract
Background and purpose:
NMDA receptors are important molecular targets of ethanol action in the CNS.
Previous studies have identified a site in membrane-associated domain 3 (M3)
of the NR1 subunit and two sites in M4 of the NR2A subunit that influence
alcohol action; the sites in NR2A M4 also regulate ion channel gating. The
purpose of this study was to determine whether mutations at the site in the
NR2A subunit corresponding to the NR1 M3 site influence alcohol action and
ion channel gating.
Experimental approach:
We investigated the effects of mutations at phenylalanine (F) 637 of the NR2A
subunit using whole-cell and single-channel patch-clamp electrophysiological
recording in transiently-transfected HEK 293 cells.
Key results:
Mutations at F637 in the NR2A subunit altered peak and steady-state
glutamate EC50 values, maximal steady-state to peak current ratios (Iss:Ip),
mean open time, and ethanol IC50 values. Differences in glutamate potency
among the mutants were not due to changes in desensitization. Ethanol IC 50
values were significantly correlated with glutamate EC50 values, but not with
maximal Iss:Ip or mean open time. Ethanol IC50 values were linearly and
inversely related to molecular volume of the substituent.
Conclusions and implications:
These results demonstrate that NR2A(F637) influences NMDA receptor
affinity, ion channel gating, and ethanol sensitivity. The changes in NMDA
receptor affinity are likely to be the result of altered ion channel gating. In
contrast to the cognate site in the NR1 subunit, the action of ethanol does not
appear to involve occupation of a critical volume at NR2A(F637).
Keywords: glutamate receptor, ethanol, electrophysiology, mutant,
desensitization, affinity

Introduction
Ethanol (EtOH) is a sedative-hypnotic agent that has been
widely used and abused throughout much of human history. Because
relevant brain concentrations of EtOH are in the millimolar range, it
interacts with low affinity with multiple molecular sites in the brain.
However, it is considered to produce its effects on central nervous
system function primarily by interacting with ligand-gated ion channels
(Peoples et al., 1996). Besides GABAA receptors, one such ion channel
that is a key target of alcohol action in the brain is the N-methyl-Daspartate (NMDA) receptor, a subtype of glutamate receptor that
contains two NR1 subunits, which bind the obligatory coagonist glycine
(Kuryatov et al., 1994; Lynch et al., 1994), and two NR2 subunits,
which bind glutamate (Laube et al., 1997; Anson et al., 1998). The
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inhibitory effects of EtOH on NMDA receptors in an array of
experimental preparations have been well-documented (Peoples,
2003). Attempts to identify the molecular locus of EtOH action on the
NMDA receptor have recently focused on a small number of amino
acids in the membrane-associated (M) domains of both the NR1 and
NR2 subunits. In particular, substitution mutations at phenylalanine
(F639 in M3 of the NR1 subunit (Ronald et al., 2001)) and methionine
(M) 823 and alanine (A) 825 in the M4 domain of the NR2A subunit
(Ren et al., 2003b; Honse et al., 2004), influence NMDA-receptor EtOH
sensitivity. Because of the high homology of the M domains between
NR1 and NR2 subunits, it is plausible that each of these sites has a
corresponding EtOH-sensitive site in the other subunit type.
Furthermore, because substitution mutations at the sites in the NR2A
subunit M4 domain identified by our laboratory affect ion channel
gating (Ren et al., 2003a, 2003b; Honse et al., 2004), we considered
it possible that the cognate site of NR1(F639) in the NR2A subunit,
F637 (Figure 1), would have a similar regulatory action on ion channel
gating. We report here that substitution mutations at NR2A(F637)
altered glutamate potency, ion channel gating and EtOH sensitivity.

Figure 1. A phenylalanine residue in M3 of the NMDA receptor NR1 subunit is
conserved in the NR2A subunit. (a) Sequences of the M3 domains of the NR1 and
NR2A subunits. The conserved phenylalanine is shown in bold type. (b) Topological
model of the NR2A subunit showing the membrane-associated domains (M1–M4),
ligand-binding domains (S1–S2, bold lines) and presumed position of F637 (shaded
circle).
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Materials and methods
Site-directed mutagenesis, cell culture and transfection
Site-directed mutagenesis in plasmids containing NR2A subunit
cDNA were performed using the QuikChange kit (Stratagene, La Jolla,
CA, USA) and all mutants were verified by double-strand DNA
sequencing. Human embryonic kidney 293 cells were transfected with
NR1-1a, NR2A and green fluorescent protein at a ratio of 2:2:1 using
the calcium phosphate transfection kit (Invitrogen, Carlsbad, CA,
USA). To protect transfected cells from the excitotoxic effects of amino
acids in the culture medium, 100 μM ketamine and 200 μM D,L-2amino-5-phosphonovaleric acid were added to the culture medium;
cells were extensively washed to remove these agents before use in
experiments. Cells were used in experiments 15–48 h after
transfection.

Electrophysiological recording
Whole-cell and single-channel patch-clamp recording were
performed at room temperature using an Axopatch 1D or Axopatch
200B (Molecular Devices, Sunnyvale, CA, USA) amplifier. In whole-cell
recordings, patch-pipettes with open tip resistances of 1–8 MΩ were
used. Series resistances of 2–7 MΩ (in glutamate concentration–
response experiments) or 5–15 MΩ (in concentration–response
experiments) were compensated by 80%. In single-channel
recordings, patch-pipettes were coated with R6101 elastomer (DowCorning, Midland, MI, USA) and had tip resistances of 7–15 MΩ
following fire polishing. Cells were voltage-clamped at −50 mV and
superfused in an external recording solution containing (in mM) 150
NaCl, 5 KCl, 0.2 CaCl2, 10 N-2-hydroxyethylpiperazine-N′-2ethanesulfonic acid (HEPES), 10 glucose and 10 sucrose (pH 7.4). Low
calcium was used to minimize calcium-dependent inactivation
(Zilberter et al., 1991); calcium concentration did not alter NMDA
receptor inhibition by EtOH (results not shown). In lifted cell
experiments, the external solution also contained 10 μM EDTA. The
intracellular recording solution in whole-cell experiments contained (in
mM) 140 CsCl, 2 Mg4ATP, 10 1,2-bis(2-aminophenoxy)ethaneN,N,N′,N′-tetraacetic acid and 10 HEPES (pH 7.2). In single-channel
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cell-attached patch recordings, the patch-pipette contained glutamate
(0.1–100 μM) glycine (50 μM) and EDTA (10 μM) in external solution.
Solutions of agonists and EtOH were applied to cells using a stepper
motor-driven solution exchange apparatus (Warner Instruments,
Hamden, CT, USA) and three-barrel square glass tubing of internal
diameter 600 μm. In glutamate concentration–response experiments,
cells were lifted off the surface of the dish to increase the speed of the
solution exchange; under these conditions 10–90% rise times for
solution exchange are ∼1.5 ms (Ren et al., 2003a). Concentration–
response data were filtered at 2 kHz (8-pole Bessel) and acquired at
5 kHz on a computer using a DigiData interface and pClamp software
(Molecular Devices). Single-channel data were filtered at 10 kHz (4pole Bessel) and acquired at 50 kHz.

Data analysis
In concentration–response experiments, IC50 or EC50 and n
(slope factor) were calculated using the equation: y=Emax/1+(IC50 or
EC50/x)n, where y is the measured current amplitude, x is
concentration, n is the slope factor and Emax is the maximal current
amplitude. Statistical differences among concentration–response
curves were determined by comparing log transformed EC50 or IC50
values from fits to data obtained from individual cells using analysis of
variance (ANOVA) followed by the Dunnett and Tukey–Kramer tests.
Comparisons among mean values of log EC50, log IC50 or maximal
steady-state to peak current ratio (Iss:Ip) for the various mutants were
made using correlation analysis and tests for linear relations of these
values to amino-acid physicochemical scales (Ren et al., 2003a) were
made using linear regression analysis.
Data from single-channel recordings were digitally filtered at
5 kHz (8-pole Bessel) and idealized using the segmentation K-means
algorithm (Qin, 2004) in the QUB software suite (available at
http://www.qub.buffalo.edu). Dwell time histograms were fitted with
multiple exponential components using Clampfit (Molecular Devices)
and mean open times were obtained from the proportionally weighted
averages of the individual components. Data were obtained from three
to six patches for each NR2A-receptor mutant tested; the average
number of opening events for each patch was 16 700.
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Materials
EtOH (95%, prepared from grain) was obtained from Aaper
Alcohol & Chemical Co. (Shelbyville, KY, USA) and all other drugs and
chemicals were obtained from Sigma Chemical Co. (St. Louis, MO,
USA).

Results
Effects of mutations at NR2A(F637) on EtOH sensitivity
To test whether mutations at NR2A(F637) affect EtOH
sensitivity, we constructed a panel of substitution mutants at this
position and performed concentration–response experiments for EtOH
inhibition in the mutant receptors. We found that all the mutations at
this site that were tested yielded functional receptors (Figure 2).
Although there is variation in amplitude among the current traces
shown in Figure 2a, values of peak density of current activated by
maximal concentrations of glutamate (300 μM) and glycine (50 μM)
varied over a large range among individual cells expressing a given
mutant subunit (the difference between high and low values of peak
current density for each mutant was 1150 pA/pF on average),
apparently as a result of variable transfection efficiency. None of the
mutant receptors had a mean value of peak current density that was
significantly different from that of the wild-type receptor (wild-type
value: 600±441 pA/pF; mean±s.e.). Figure 2a also shows that all the
mutant subunits were inhibited by EtOH. Concentration–response
curves for EtOH inhibition were essentially parallel to each other, as
the slope factors of the curves did not differ significantly, but statistical
analysis revealed that there was a highly significant effect of mutations
at this site on EtOH IC50 (ANOVA, P<0.0001) and significant
differences in EtOH IC50 values among the various mutants. EtOH IC50
values were significantly increased in four of the mutants. Tryptophan
substitution at F637 produced the greatest increase in EtOH IC50,
whereas alanine or serine substitutions significantly decreased the
EtOH IC50.
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Figure 2. Effect of EtOH on NMDA-activated current in cells expressing NR2A(F637)
mutant subunits. (a) Records are currents activated by 10 μM glutamate (Glu) and
50 μM glycine in the absence and presence of 100 mM EtOH in human embryonic
kidney (HEK) 293 cells coexpressing NR1 and wild-type (WT) NR2A or various
NR2A(F637) substitution mutant subunits. (b) Concentration–response curves for
EtOH inhibition of current activated by 10 μM glutamate (Glu) and 50 μM glycine in
HEK 293 cells coexpressing NR1 and wild-type NR2A (WT) or various NR2A(F637)
substitution mutant subunits. Data points are means of five to 12 cells and curves
shown are the least-squares fits to the equation given in Materials and methods. (c)
Bar graph shows IC50 values for EtOH in cells expressing the various NR2A(F637)
mutant subunits. Asterisks indicate IC50 values that differed significantly (ANOVA and
Dunnett's test; *P<0.05, **P<0.01) from the IC50 for WT NR1/NR2A subunits.

Effects of mutations at NR2A(F637) on agonist sensitivity and
desensitization
To test whether mutations at NR2A(F637) also affected
physiological characteristics of the receptor such as glutamate
sensitivity and desensitization, we performed concentration–response
experiments for glutamate in the series of mutant receptors using a
rapid solution exchange apparatus in lifted cells (Figure 3). For the
series of mutants, highly significant differences were obtained in the
EC50 values for glutamate-activated peak (P<0.0001; ANOVA) and
steady-state (P<0.0001; ANOVA) current and for the steady-state to
peak current ratio (Iss:Ip; P<0.0001; ANOVA). The EC50 for glutamate
activation of peak current was not altered by the majority of the
mutations at NR2A(F637), but was strikingly decreased by substitution
of tryptophan, but increased by substitution of serine at this site. Hill
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coefficients of the glutamate concentration–response curves for
activation of peak current did not differ significantly from the wild-type
value in any of the mutants tested. EC50 values for glutamateactivated steady-state current, however, showed more variation
compared with peak current: EC50 values were significantly increased
in one of the mutants and decreased in three of the mutants. In
particular, the glutamate EC50 value was markedly decreased in the
NR2A(F637W) mutant. Apparent desensitization was also affected by
mutations at NR2A(F637). Substitutions at this site decreased the Iss:Ip
in two mutants (Figure 4), with the maximal effect on apparent
desensitization being produced by methionine substitution, which
decreased Iss:Ip by over twofold.

Figure 3. NR2A(F637) mutations can alter EC50 values for both peak and steady-state
glutamate-activated current. Concentration–response curves for glutamate (in the
presence of 50 μM glycine) activation of peak (a) and steady-state (b) current in lifted
human embryonic kidney 293 cells expressing NR1/NR2A or NR1/NR2A(F637) mutant
subunits. Data points are means of five to eight cells and curves shown are the leastsquares fits to the equation given in Materials and methods. Bar graphs show peak (c)
and steady-state (d) EC50 values for glutamate in lifted cells expressing the various
NR2A(F637) mutant subunits. Asterisks indicate EC50 values that differed significantly
(ANOVA and Dunnett's test; *P<0.05, **P<0.01) from the EC50 for wild-type NR1/NR2A
subunits.
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Figure 4. Effect of NR2A(F637) mutations on desensitization kinetics. (a) Traces
illustrating desensitization of current activated by 300 μM glutamate (in the presence
of 50 μM glycine) in lifted cells expressing wild-type (WT) NR1/NR2A,
NR1/NR2A(F637W) and NR1/NR2A(F637M) subunits. (b) Average values of Iss:Ip of
glutamate-activated current; n=5–8 cells. Asterisks indicate values that differed
significantly (ANOVA and Dunnett's test; **P<0.01) from the value for WT NR1/NR2A
subunits.
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In a previous study, we demonstrated that for a series of
mutants at a position in the M4 domain, changes in steady-state
glutamate EC50 were attributable to changes in desensitization (Ren et
al., 2003a). Analysis of the results obtained in mutants at
NR2A(F637), however, revealed that the peak and steady-state
glutamate EC50 values were highly correlated (Figure 5), but values of
maximal Iss:Ip were not correlated either with glutamate peak or
steady-state EC50 values.

Figure 5. Relation between NMDA-receptor agonist potency and desensitization in
NR2A(F637) mutant subunits. (a) Graph plots steady-state vs peak EC50 values for
glutamate in the various NR2A(F637) mutant subunits. Data points are labeled with
the substituted amino acid for the various mutants at NR2A(F637). The line shown is
the least squares fit to the data; glutamate peak and steady-state EC50 were
significantly correlated (R2=0.900, P<0.0001). (b) Graph plots steady-state and peak
log EC50 values for glutamate vs the Iss:Ip of glutamate-activated current in the various
NR2A(F637) mutant subunits. Maximal Iss:Ip for glutamate was not correlated with
either peak glutamate log EC50 (R2=0.340, P>0.05) or steady-state glutamate log EC50
(R2=0.075, P>0.05). The lines shown are the least squares fits to the data.
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Effects of mutations at NR2A(F637) on mean open time
NR2A subunit mutations that alter its alcohol sensitivity may
also influence measures of ion channel gating (Ren et al., 2003a;
Honse et al., 2004). We thus tested effects of the various mutations at
NR2A(F637) on mean open time using single-channel recording in cellattached patches (Figure 6). Patches from cells expressing wild-type
NR1 and NR2A subunits had open time distributions that could be
fitted with three exponential components (Table 1). Each of the
substitution mutations tested significantly decreased mean open time
to values in the range 0.5–2 ms (Table 1). In contrast to the results
obtained in patches from cells expressing the wild-type NR2A subunit,
the open time distributions in five of the 12 mutant subunits could be
adequately fitted with two exponential components. This is illustrated
by the open time distribution from a patch containing NR2A(F637W)
mutant subunits, as shown in Figure 6b and d.

Figure 6. Mutations at NR2A(F637) can alter mean open time of the NMDA receptor.
Traces are currents activated by glutamate, 10 μM, in the presence of 50 μM glycine
and 10 μM EDTA in cell-attached patches in cells expressing wild-type NR1/NR2A (a)
or NR1/NR2A(F637W) (b) subunits. The pipette potential was −50 mV; channel
openings are downward. Open time histograms from cell-attached patches containing
wild-type NR1/NR2A (c) or NR1/NR2A(F637W) (d) subunits. Solid curves indicate
maximum likelihood multiple exponential fits to the data and dotted curves indicate
the individual exponential components. Traces in (a) and (b) and corresponding
distributions in (c) and (d) are from the same individual patches; similar results were
obtained in two to four other patches.
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Table 1. Mean open times in NR2A(F637) mutants
Substituent at
NR2A(F637)

τ1 (ms)

τ2 (ms)

τ3 (ms)

Mean open time
(ms)

Phe

0.18±0.022

2.2±0.38

8.5±1.8

3.9±0.95

Ala

0.33±0.047

1.9±0.11

—

1.1±0.071**

Asn

0.25±0.030

1.3±0.25

2.6

0.80±0.065**

Asp

0.22±0.038

1.0±0.21

—

0.53±0.074**

Cys

0.16±0.044

0.93±0.21

4.3±1.4

1.2±0.16**

Gly

0.24±0.035

1.2±0.20

3.0±0.055

0.86±0.092**

Ile

0.28±0.048

2.0±0.26

—

1.1±0.11**

Met

0.18±0.014

1.4±0.16

—

0.75±0.11**

Ser

0.16±0.033

1.2±0.19

4.3±0.64

1.2±0.15**

Thr

0.22±0.014

1.3±0.17

3.4

0.79±0.039**

Trp

0.41±0.074

3.4±0.44

—

1.9±0.36**

Tyr

0.20±0.031

1.7±0.38

3.7±0.23

1.6±0.13**

Val

0.17±0.023

1.1±0.14

3.4±0.035

0.98±0.089**

Abbreviation: WT, wild-type.
Values are the means±s.e.m. of data obtained from three to six patches. Time
constants (τ) for individual components were obtained as described in Materials and
methods.
Mean open times for all of the mutant receptors were significantly different from the
value obtained for WT receptors (ANOVA and Dunnett's test; **P<0.01).

Relation of agonist sensitivity, desensitization and
mean open time to EtOH sensitivity in mutants at
NR2A(F637)
Because mutations at NR2A(F637) caused significant variation in
glutamate EC50 and maximal Iss:Ip values in addition to EtOH IC50
values, it is possible that the observed changes in EtOH sensitivity
among the mutants could result from changes in agonist potency or
ion channel gating kinetics. Plotting EtOH IC50 values against
glutamate EC50 or maximal Iss:Ip values revealed that EtOH sensitivity
of the mutants was significantly correlated with both glutamate peak
and steady-state EC50 values (Figure 7a). As would be expected from
the observation that glutamate EC50 values were not correlated with
maximal Iss:Ip values, EtOH IC50 was not correlated with maximal Iss:Ip
(Figure 7b). In addition, there was no difference between EtOH
inhibition of peak and steady-state current in the most highly
desensitizing mutants, NR2A(F637M) and NR2A(F637N) (results not
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shown). Similarly, there was no correlation between EtOH IC50 values
and mean open time (Figure 7c).

Figure 7. Relation of agonist potency, ion channel gating and substituent molecular
volume to EtOH sensitivity in NMDA receptors containing NR2A(F637) mutant
subunits. Graphs plot log IC50 for EtOH vs log EC50 values for glutamate peak and
steady-state current (a) maximal Iss:Ip for glutamate (b), mean open time (c) and
substituent molecular volume in Å3 (d) for the various substituents at NR2A(F637).
Data points are labeled with the substituted amino acid for the various mutants at
NR2A(F637). The lines shown are the least squares fits to the data. Highly significant
correlations were obtained between log EtOH IC50 and log EC50 for glutamate
activation of peak (R2=0.626, P<0.001) and steady-state (R2=0.743, P<0.0001)
current, but not glutamate maximal Iss:Ip (R2=0.001, P>0.05) or mean open time
(R2=0.006, P>0.05). A significant linear relation was obtained between log EtOH IC50
and molecular volume (R2=0.587; P<0.005), but not hydropathy (R2=0.001, P>0.05),
polarity (R2=0.003, P>0.05) or hydrophilicity (R2=0.276, P>0.05).

The observation that changing the substituent at NR2A(F637)
alters EtOH sensitivity could be an indication that the EtOH molecule is
physically interacting with this site in some manner. If there is such an
interaction, then this should be evident by the presence of a significant
linear relation for the series of mutants between the EtOH IC50 value
and at least one physicochemical measure of the amino-acid
substituent at this position. To evaluate this possibility, we performed
linear regression analysis of the EtOH log IC50 vs hydropathy,
hydrophilicity, polarity (results not shown) and molecular volume of
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the substituent (Figure 7d). EtOH sensitivity was not linearly related to
hydropathy, polarity or hydrophilicity, but was significantly linearly
related to molecular volume of the amino acid at NR2A(F637).

Discussion
The results of this study have shown that NR2A(F637), the
cognate position of the alcohol-sensitive site NR1(F639), regulates
EtOH sensitivity, glutamate potency, desensitization and mean open
time. We have shown previously that in a region of the NR2A M4
domain, there is considerable overlap between residues influencing
alcohol sensitivity and those regulating ion channel gating (Ren et al.,
2003a, 2003b; Honse et al., 2004). In mutants at M823 in this region,
changes in steady-state glutamate potency were attributable to altered
desensitization resulting in a greater or lesser degree of trapping of
the agonist bound to the receptor in the desensitized state (Ren et al.,
2003a). In the present study, however, there was a significant effect
of mutations at F637 on peak and steady-state glutamate EC50, but
steady-state glutamate EC50 was not correlated with maximal Iss:Ip,
indicating that this site is able to influence agonist potency in a
manner that is independent of changes in desensitization. The
mechanism for this is unclear at present, but could possibly involve a
subtle conformational change at the level of F637 that results in longrange modulation of the S2 agonist-binding domain. Smothers and
Woodward (2006) similarly demonstrated that mutations at NR1(F639)
could change glycine peak EC50 values, but it is not known whether
these values are related to desensitization, as these investigators did
not report values of glycine steady-state EC50 or maximal Iss:Ip.
In a previous study, we found that mutations at NR2A(M823) in
M4 could dramatically increase or decrease mean open time (Ren et
al., 2003a) in a manner that was related to the hydrophobicity of the
substituent. In the present study, we found that mean open time was
also altered by mutations at NR2A(F637), but in all cases it was
significantly decreased compared with the wild-type value. This
decrease was primarily attributable to the relative absence or lower
proportion of the longest component of openings. It should be noted
that the intermediate component of open time in the wild-type
NR1/NR2A receptor has been shown to be attributable to block by low
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levels of contaminating Mg2+ (Popescu and Auerbach, 2003; Schorge
et al., 2005). Although solutions in the present study contained 10 μM
EDTA and were prepared using ultrapure salts, much higher chelator
concentrations are required to reduce Mg2+ concentration sufficiently
to completely remove the block (Popescu and Auerbach, 2003). Thus,
the intermediate open time in the present study most probably
represents a fraction of the longer openings that were shortened by
Mg2+ block. Nevertheless, the mean open time of 3.9 ms that we
observed in wild-type NR1/NR2A subunits is within the range of mean
open time values from recent studies of native and recombinant
receptors in which this component was absent or present (2.8–4.1 ms)
(Rycroft and Gibb, 2004; Schorge et al., 2005; Yuan et al., 2005), and
the presence of this intermediate component does not alter the
conclusion that the mutations at F637 shortened the longest open time
component. We observed similar values for open time in wild-type and
mutant receptors in outside-out patches in the presence of a high
concentration of EDTA (results not shown). Thus mutations at F637
decreased the lifetime of the longest open state and the wild-type
phenylalanine residue at this site appears to interact optimally with
one or more adjacent residues to slow the ion channel-closing rate
from this state. There was little variation in mean open time among
the mutants excluding tryptophan; the average of these open times
was 0.99±0.088 ms. Although mean open time was not dependent on
the molecular volume of the substituent at F637, the observation that
the mean open times for the tryptophan and tyrosine mutants were
somewhat higher (1.9 and 1.6 ms, respectively) may indicate that the
bulky side chains of these amino acids are able to interact at least
partially with the residues adjacent to this position that regulate the
ion channel-closing rate.
An alanine mutation at NR1(F639) was shown to decrease EtOH
sensitivity (Ronald et al., 2001) and a positive linear relation has
subsequently been demonstrated between the molecular volume of the
substituent at NR1(639) and the inhibition by EtOH (Smothers and
Woodward, 2006). In the present study, however, we observed a
significant negative linear relation between EtOH IC50 values and
molecular volume at NR2A(637) for a series of substitution mutants.
Thus, despite the high degree of conservation in this region between
the NR1 and NR2A subunits, identical substitution mutations produced
opposite effects. A possible explanation for this difference may be that
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this region in the NR2C subunit has been reported to be shifted about
four amino acids more externally relative to the NR1 subunit
(Sobolevsky et al., 2002), so that this residue in each subunit type
may interact with different regions of adjacent domains. However,
whether this displacement occurs in the NR2A subunit has not been
reported.
We previously observed that EtOH inhibition of a series of
NMDA-receptor mutants at NR2A(M823) was inversely related to
desensitization (Ren et al., 2003b) and other investigators have
demonstrated that EtOH inhibits α-amino-3-hydroxy-5methylisoxazole-4-propionic acid receptors by stabilizing
desensitization (Moykkynen et al., 2003). In the present study, there
was no correlation between EtOH IC50 values and desensitization and
there was no difference in EtOH inhibition of peak vs steady-state
current in the most highly desensitizing mutants, but there were
negative correlations between EtOH IC50 and glutamate potency, such
that mutants that were activated by lower concentrations of glutamate
were less sensitive to EtOH. We consider it improbable that glutamate
potency per se influences EtOH sensitivity in this series of mutants, as
it is now well established that the action of EtOH is independent of
glutamate concentration (Peoples, 2003). It is more probable that the
same factors that influence EtOH sensitivity in this series of mutants
also affect glutamate potency perhaps by the same, or a very similar,
mechanism. It is also possible that mutations that influence mean
open time could alter EtOH sensitivity, as EtOH is known to inhibit
NMDA receptors by a mechanism that involves a decrease in mean
open time (Lima-Landman and Albuquerque, 1989; Wright et al.,
1996). In the present study, however, there was no such correlation
between mean open time and EtOH sensitivity. As discussed above,
mean open time was significantly decreased by all of the mutations at
F637, whereas EtOH IC50 values could be either increased or decreased
depending on the substituent. Thus, the changes in EtOH IC50 values
observed in this study do not appear to be secondary to changes in
glutamate potency or measures of ion channel gating.
A number of studies on GABAA and glycine-receptor ion channels
have reported that the molecular volume of alcohol or anesthetic
target sites influences the modulation of the ion channel by alcohols or
anesthetics (Wick et al., 1998; Ye et al., 1998; Koltchine et al., 1999;
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Yamakura et al., 1999; Kash et al., 2003). Similarly, the ability of
alcohols or anesthetics to modulate the activity of these receptors may
also depend on the molecular volume of the anesthetics (Wick et al.,
1998; Jenkins et al., 2001; Krasowski et al., 2001; Kash et al., 2003).
Such observations are consistent with the view that EtOH and similar
molecules modify receptor function by occupying a critical volume
within the site (Wick et al., 1998). In the present study, we observed
that increases in molecular volume of the substituent at NR2A(F637)
decreased the potency of EtOH for inhibition of the ion channel. This
observation is difficult to reconcile with a model in which EtOH binds to
the amino-acid side chain at this position and inhibits receptor function
by occupation of a critical volume, especially in light of our observation
that although EtOH acts by decreasing mean open time (LimaLandman and Albuquerque, 1989; Wright et al., 1996), mean open
time and side-chain molecular volume were not related in the series of
mutants (R2=0.284, P>0.05; results not shown). The inverse relation
between EtOH potency and molecular volume at this site may instead
indicate that this site either presents a barrier to the access of EtOH to
a nearby site of action or that the amino-acid side chain at this site
interacts with an adjacent site of EtOH action in a manner that hinders
the effect of EtOH. Thus, decreases in molecular volume at
NR2A(F637) could either increase the access of EtOH to a site of action
or ease a steric hindrance tending to act against the inhibitory effect of
EtOH. Further studies will be required to distinguish between these
possibilities.
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Abbreviations
ANOVA analysis of variance
EtOH

ethanol

Iss:Ip

steady-state to peak current ratio

M

membrane-associated domain

NMDA N-methyl-D-aspartate
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